213 results
Search Results
Now showing 1 - 10 of 213
Publication Metadata only Doripenem pharmacokinetics in hemodialysis(2020-07-01) Sirin Phenphinan; Aporanee Chaiyakum; Suphat Subongkot; Chantana Aromdee; Porpon Rotjanapan; Montira Assanatham; Siriluk Jaisue; Khon Kaen University; Faculty of Medicine, Ramathibodi Hospital, Mahidol Universityof carbapenem efficacy. Doripenem is primarily eliminated by kidneys and can be removed by hemodialysis. The purpose of this study was to determine the pharmacokinetics of doripenem in hemodialysis patients with moderate to severe infections. Methods... This prospective, single-center study was conducted in end-stage renal disease patients undergoing hemodialysis and receiving doripenem. Low-flux hemodialysis was performed for 4 hours. Blood and dialysate samples were collected during hemodialysisPublication Metadata only Effect of ultrafiltration rate in long interdialytic interval hemodialysis session versus average weekly ultrafiltration rate on mortality rate and adverse cardiovascular outcomes in maintenance hemodialysis patients(2020-09-01) Kornchanok Vareesangthip; Thawee Chanchairujira; Kriengsak Vareesangthip; Faculty of Medicine, Siriraj Hospital, Mahidol University© 2020 Faculty of Medicine Siriraj Hospital, Mahidol University. Objective: Cardiovascular events are more commonly observed during hemodialysis sessions after a long interdialytic interval compared to average weekly hemodialysis sessions..., and ultrafiltration rate (UFR) was reported to be associated with cardiovascular outcomes. Whether the UFR during hemodialysis sessions after a long interdialytic interval is a better predictor of cardiovascular outcome than the average weekly UFR is unknown. MethodsItem Metadata only Factors related to quality of life among patients with end stage renal disease receiving hemodialysis(Mahidol University. Mahidol University Library and Knowledge Center, 2016) Vu, Dinh Tien, 1979-; Orapan Thosingha; Wimolrat PuwarawuttipanitItem Metadata only Nutrition status among hemodialysis patients receiving anabolic steroid(Mahidol University. Mahidol University Library and Knowledge Center, 2009) Kallaya Kansumrit; Chanida PachotikarnItem Metadata only Predicting Factors of Health-related Quality of Life Among Persons with End-stage Renal Disease Receiving Hemodialysis at a Tertiary Level Hospital in Nepal(2024-01-01) Gahatraj J.; Visudtibhan P.J.; Junda T.; Butsing N.; Mahidol UniversityBackground: End-stage renal disease (ESRD) puts tremendous burdens upon affected patients and their support persons in Nepal. The health-related quality of life (HRQoL) among Nepalese persons with hemodialysis-dependent ESRD is not well understood.... This study aimed to examine HRQoL and its predicting factors among persons undergoing hemodialysis in Nepal. Methods: A purposive sampling was applied to recruit 106 persons with ESRD receiving hemodialysis at a tertiary hospital in Nepal between OctoberItem Metadata only The relationship between stimuli frame and structure provider with uncertainty in illness in structure provider with uncertainty in illness in patients with hemodialysis(Mahidol University. Mahidol University Library and Knowledge Center, 2008) Wattana Langnak; Wonnapha PrapaipanichPublication Metadata only Changes in pulmonary restrictive parameters by intensive home hemodialysis: a case report(2020-08-03) Thatsaphan Srithongkul; Owen D. Lyons; Rose Faratro; Christopher T. Chan; Women's College Hospital; University of Toronto; University Health Network University of Toronto; Mahidol UniversityBACKGROUND: Patients with End-Stage Renal Disease (ESRD) are at an increased risk for restrictive lung disease due to accumulation of uremic toxins and volume overload. Hemodialysis is the preferred treatment for improving lung function in dialysis... patients. However, the effects of fluid removal and solute clearance by hemodialysis on lung function remain unclear. CASE PRESENTATION: We report a case of restrictive lung disorder in a hemodialysis patient, who showed improvement in both clinicalPublication Metadata only Knowledge management model for quality improvement in the hemodialysis unit of a non-profit private hospital, Bangkok, Thailand(2012-10-04) Somsri Sumet; Nawarat Suwannapong; Nopporn Howteerakul; Chuthipat Thammarat; Mahidol University; Saint Louis Hospital ThailandPurpose: This study seeks to use a knowledge management (KM) model as a tool to improve the quality of service in a hemodialysis unit. Design/methodology/approach: A quasi-experimental, one group pre-test-post-test study was conducted over a period... of ten months at a hemodialysis unit. All of the staff in the unit, and all of the patients who came for hemodialysis at the outpatient department during the study period, were invited to participate. Self-administered questionnaires were used to measurePublication Metadata only Symptom clusters in patients with end-stage renal disease undergoing hemodialysis(2020-01-01) Suchira Chaiviboontham; Noppawan Phinitkhajorndech; Juthamas Tiansaard; Faculty of Medicine, Ramathibodi Hospital, Mahidol University© 2020 Chaiviboontham et al. This work is published and licensed by Dove Medical Press Limited. Background: End-stage renal disease (ESRD) patients undergoing hemodialysis have to face many symptoms from disease progression and treatment... undergoing hemodialysis will lead to effective symptom management and maximize benefits for the patients. The purpose of this study was to explore the symptom clusters of ESRD patients undergoing hemodialysis. Materials and Methods: The sampleItem Metadata only Microparticles at the crossroads of the gut-kidney axis: Mechanistic drivers and therapeutic horizons in hemodialysis(2026-01-01) Bhunyakarnjanarat T.; Leelahavanichkul A.; Chancharoenthana W.; Bhunyakarnjanarat T.; Mahidol UniversityChronic kidney disease (CKD) and end-stage kidney disease (ESKD) pose sig-nificant global health challenges, with hemodialysis serving as a vital treatment for ESKD patients. Despite its life-sustaining role, hemodialysis is associated with elevated... on their contribution to uremic toxicity and clinical outcomes in hemodialysis patients. We explore how MPs, originating from endothelial cells, platelets, and gut microbiota, transport bioactive molecules, intensify inflammation, and impair endothelial function